EPIVIN: A PHASE II DOUBLE-BLIND RANDOMISED CONTROL TRIAL INVESTIGATING THE USE OF EPIGALLOCATECHIN-3-GALLATE (VEREGEN®, CATEPHEN®) VS PLACEBO IN THE TREATMENT OF USUAL-TYPED VULVAL INTRAEPITHELIAL NEOPLASIA

Authors
Category Primary study
JournalINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Year 2019
This article has no abstract
Epistemonikos ID: 7ddd99b58493bf149450d72362c4b0ab06829e55
First added on: Dec 20, 2022